A PYMNTS Company

US: FTC options limited in Phoebe Putney healthcare merger settlement

By  |  August 23, 2013

The US Federal Trade Commission announced an agreement has been reached with a hospital authority in Georgia and Phoebe Putney Health System regarding the healthcare group’s buyout of a hospital. According to the regulator, while a settlement has been reached between the parties that includes the two must notify the FTC of any future transactions and prevents the exclusion of potential entrants into the local market.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The watchdog is limited, however, in its options. While the regulator would have preferred to require hospital divestures of the health system company, the state has “unique” Certificate of Need laws that prevent any forced sales. The FTC therefore could not require the hospitals to become independent competition in the market.

    The FTC opened its case against the parties following Phoebe Putney’s acquisition of the Palmyra Park Hospital; a review of the deal found threats to competition in six counties in the state. Despite the limitations, a statement by the FTC’s Director of the Bureau of Competition Deborah Feinstein described the settlement as a victory following the US Supreme Court’s ruling that the hospital buy could be reviewed by federal authorities, limiting the scope of state-level antitrust immunity. “Regrettably,” said Feinstein, “that legal victory will not undo the acquisition’s clear harm to competition.”

    Full Content: My South West GA

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.